Abstract:Background: Iron deposition within the substantia nigra (SN) has been postulated to play a vital role in Parkinson's disease (PD). The aim of this study was to explore the inherent link of PD patients between their substantia nigra iron accumulation and clinical status using quantitative susceptibility mapping (QSM) which is now considered to be the only quantitative imaging technique of brain iron deposition. Methods: 44 PD patients and 31 age- and gender-matched healthy controls underwent quantitative susceptibility mapping (QSM) were recruited in this study. We firstly divided the patients into mild symptom severity (MSP) and advanced symptom severity (ASP) groups concerning their disease stage, aiming to illuminate the relationship between iron deposition in SN of PD and disease progression. Then, we classified the patients with Parkinson's disease into three subgroups: tremor-dominant PD (TD), akinetic/rigidity-dominant PD (AR), mixed PD (M) according to their dominant motor symptoms in order to investigate whether there are any effects of SN iron accumulation to different subtypes of PD patients. Results: Compared to healthy controls, patients with PD have increased QSM magnetic values in the substantia nigra (138.039 +/- 37.320 vs 179.553 +/- 65.715; P = 0.001). More prominent statistically significance of the difference of SN iron deposition between healthy controls (HC) and advanced symptom severity (ASP) subgroup was displayed (138.039 +/- 37.320 vs 232.827 +/- 92.040; P < 0.001). Besides, among the three clinical phenotypes both TD and AR subgroup showed significant difference compared with healthy controls concerning the QSM values (138.039 +/- 37.320 vs 185.864 +/- 99.851; P = 0.013; 188.148 +/- 52.958 vs 138.039 +/- 37.320; P = 0.001). Furthermore, the iron content in the SN of PD patients was significantly correlated with the Hoehn-Yahr stage, the Unified Parkinson's Disease Rating Scale (UPDRS), Montgomery Asberg Depression Rating Scale (MADRS) and Hamilton Anxiety Scale (HAMA) scores (r = 0.417, P = 0.005; r = 0.300, P = 0.048; r = 0.540, P < 0.001; r = 0.553, P < 0.001). In MSP the significantly correlation was displayed only in MADRS, HAMA scores (r = 0.429, P = 0.013; r = 0.492, P = 0.004), when disease progressed into advanced severity stage all these clinical measures (Hoehn-Yahr stage, UPDRS-3, UPDRS, HAMA, and MADRS scores) we had recruited into this study shown prominent correlation to SN iron content (r = 0.650, P = 0.030; r = 0.709, P = 0.015; r = 0.708, P = 0.015; r = 0.758, P = 0.007; r = 0.683, P = 0.020). In the three phenotypes the correlation between iron content and MADRS, HAMA scores (r = 0.686, P = 0.002; r = 0.633, P = 0.006) was found in AR subgroups exclusively. Conclusions: Patients with PD exhibited significantly higher magnetic susceptibility values, especially in those who are in advanced disease severity stage, which confirmed that iron accumulation in the SN is in line with Parkinson's disease progression. Furthermore, we testified that there are actually some inherent effects of substantia nigra iron deposition to the clinical symptoms of Parkinson's disease. Moreover, it seems that akinetic/rigidity-dominant PD subgroup was affected most by SN iron accumulation.

[Brain iron deposition increases in the bilateral substantia nigra of patients with medication-overuse headache: a quantitative susceptibility mapping analysis]

Increased Iron Deposition in Nucleus Accumbens Associated with Disease Progression and Chronicity in Migraine.

Voxel-based quantitative susceptibility mapping revealed increased cerebral iron over the whole brain in chronic migraine

Altered Cerebral Iron Over the Whole Brain in Chronic Migraine Using Voxel-Based Quantitative Susceptibility Mapping

The increased iron deposition of the gray matter over the whole brain in chronic migraine: An exploratory quantitative susceptibility mapping study

Brain Iron Deposition in White Matter Hyperintensities: a 3-T MRI Study

Brain Iron Deposits in Thalamus is an Independent Factor for Depressive Symptoms Based on Quantitative Susceptibility Mapping in an Older Adults Community Population

Quantitative Susceptibility Mapping of Brain Iron Relating to Cognitive Impairment in Hypertension

Quantitative Susceptibility Mapping to Evaluate Brain Iron Deposition and Its Correlation with Physiological Parameters in Hypertensive Patients.

Quantitative susceptibility mapping of subcortical iron deposition in Parkinson disease and multiple system atrophy: clinical correlations and diagnostic implications

Characterizing Brain Iron Deposition in Patients with Subcortical Vascular Mild Cognitive Impairment Using Quantitative Susceptibility Mapping: A Potential Biomarker

[Altered Brainstem Volume in Medication-overuse Headache: A Pilot Magnetic Resonance Imaging Evaluation].

Quantitative susceptibility mapping reveals brain iron accumulation in minimal hepatic encephalopathy: associations with neurocognitive changes

Quantitative susceptibility mapping for iron monitoring of multiple subcortical nuclei in type 2 diabetes mellitus: a systematic review and meta-analysis

Putamen iron quantification in diseases with neurodegeneration: a meta-analysis of the quantitative susceptibility mapping technique

Quantifying Iron Deposition Within the Substantia Nigra of Parkinson's Disease by Quantitative Susceptibility Mapping

Systematic Review: Quantitative Susceptibility Mapping (QSM) of Brain Iron Profile in Neurodegenerative Diseases

Quantitative Susceptibility Mapping for Drug-Addicted Human Brain

Alterations in brain iron deposition with progression of late-life depression measured by magnetic resonance imaging (MRI)-based quantitative susceptibility mapping

Increased Iron Deposition on Brain Quantitative Susceptibility Mapping Correlates with Decreased Cognitive Function in Alzheimer's Disease.

Altered Brain Iron Depositions from Aging to Parkinson's Disease and Alzheimer's Disease: A Quantitative Susceptibility Mapping Study